Literature DB >> 2419359

Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis.

D O Willenborg, P Sjollema, G Danta.   

Abstract

Lewis rats, treated from birth with a rabbit anti-rat IgM antiserum are B-cell and immunoglobulin deficient. When sensitized with myelin basic protein (BP) and complete Freund's adjuvant (CFA), these rats do not make detectable antibodies to BP, nor do they develop clinical or histopathological evidence of allergic encephalomyelitis (EAE). We show here that transfer of anti-BP antibody containing serum to BP sensitized Ig deficient rats results in subsequent development of EAE. We also demonstrate that BP sensitized Ig deficient rats which do not develop EAE, nevertheless generate effector cells capable of transferring disease, and thus specific T-cell function is not inhibited by the anti-Ig treatment. Finally, Ig deficient rats were shown to be perfectly adequate recipients of passively induced EAE.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419359     DOI: 10.1016/0165-5728(86)90111-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Treating human autoimmune disease by depleting B cells.

Authors:  R J Looney
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 2.  Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Anne H Cross; Jennifer L Stark
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.

Authors:  Monica K Mann; Avijit Ray; Sreemanti Basu; Christopher L Karp; Bonnie N Dittel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

Review 4.  A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Avijit Ray; Monica K Mann; Sreemanti Basu; Bonnie N Dittel
Journal:  J Neuroimmunol       Date:  2010-12-10       Impact factor: 3.478

5.  Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.

Authors:  Anne-Christine Flach; Tanja Litke; Judith Strauss; Michael Haberl; César Cordero Gómez; Markus Reindl; Albert Saiz; Hans-Jörg Fehling; Jürgen Wienands; Francesca Odoardi; Fred Lühder; Alexander Flügel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

6.  B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice.

Authors:  Jeri-Anne Lyons; Michael J Ramsbottom; Robert J Mikesell; Anne H Cross
Journal:  J Autoimmun       Date:  2008-06-09       Impact factor: 7.094

7.  Immunochemical specificity of antisera raised against the synthetic encephalitogenic peptide SH624, residues 59-74 of the myelin basic protein.

Authors:  N T Potter; G A Hashim; E D Day
Journal:  Neurochem Res       Date:  1987-01       Impact factor: 3.996

Review 8.  Discovery and Function of B-Cell IgD Low (BDL) B Cells in Immune Tolerance.

Authors:  Mohamed I Khalil; Cody J Gurski; Landon J Dittel; Savannah D Neu; Bonnie N Dittel
Journal:  J Mol Biol       Date:  2020-06-29       Impact factor: 5.469

9.  Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice.

Authors:  S D Wolf; B N Dittel; F Hardardottir; C A Janeway
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.

Authors:  Francesco Mannara; Tony Valente; Josep Saura; Francesc Graus; Albert Saiz; Beatriz Moreno
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.